WASHINGTON (WGHP) — U.S. government-run vaccine sites are expected to stop offering the Johnson & Johnson coronavirus vaccine after multiple people developed blood clots, according to the New York Times.
The announcement is expected Tuesday after six people in the U.S. developed blood clots within two weeks of getting the vaccine. The Centers for Disease Control and the Food and Drug Administration is working to determine if there is a link between the vaccine and the blood clots.
The Times reported that one woman died from a possibly vaccine-related clot. Another is in critical condition.
All six of the patients were women between ages 18 and 48.
The decision to halt use of the vaccine comes after the U.S. had already used the Johnson & Johnson vaccine on nearly 7 million people, according to the New York Times.
Are you more or less likely to get vaccinated after seeing this update re: Johnson & Johnson’s COVID-19 vaccine?— WANE 15 (@wane15) April 13, 2021
The government is only recommending that states halt usage of the vaccine but is not requiring them to stop.
Indiana’s Department of Health has notified all vaccination clinics using the single-dose Johnson & Johnson COVID-19 vaccine to pause its use. The state has not received official notification of a directive to pause but is doing so out of an abundance of caution, according to a release.
The health department will be sending the two-dose Moderna vaccine to the Indianapolis Motor Speedway, which is conducting mass vaccination clinics today, so that Hoosiers can continue to get vaccinated without interruption. The department is also working with other clinics that were scheduled to use the Johnson & Johnson vaccine in the immediate future.
Indiana Department of Health Chief Medical Officer Lindsay Weaver, M.D., is scheduled to hold a brief press conference at 9:15 a.m. at the Speedway.